4//SEC Filing
dEsparbes Eric 4
Accession 0000899243-23-000958
CIK 0001580063other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:05 PM ET
Size
6.1 KB
Accession
0000899243-23-000958
Insider Transaction Report
Form 4
dEsparbes Eric
Chief Financial Officer
Transactions
- Disposition to Issuer
Series X Preferred Stock
2023-01-03−95→ 0 total
Footnotes (2)
- [F1]On November 10, 2022, the Company's board of directors (the "Board") declared a dividend of one one-thousandth of a share of Series X Preferred Stock, par value $0.001 per share (the "Preferred Stock"), for each outstanding share of common stock to common stockholders of record at 5:00 p.m. Eastern Time on November 21, 2022, in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on November 21, 2022. As a result, the Reporting Person received the shares of Preferred Stock set forth above. The Preferred Stock was not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company.
- [F2]On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock.
Documents
Issuer
BIORA THERAPEUTICS, INC.
CIK 0001580063
Entity typeother
Related Parties
1- filerCIK 0001622268
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:05 PM ET
- Size
- 6.1 KB